Incidence and efficacy of strategies for preventing hepatic encephalopathy following transjugular intrahepatic portosystemic shunt: A meta-analysis

Figure 2 The incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in the drug intervention group and the untreated group. A: The incidence of hepatic encephalopathy (HE) at different times; B: The incidence of HE after transjugular intrahepatic portosystemic shunt in patients with or without a history of HE.